Corrigendum to “Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients – a longitudinal study over 20 years” [J Hosp Infect 135 (2023) 55–58] - 30/01/25

N. Hassoun-Kheir ^{a, ⁎} , N. Buetti ^{a, b}, V. Olivier ^c, M. Perez ^a, J. Frossard ^a, G. Renzi ^d, J. Schrenzel ^{d, e}, P. Saudan ^c, S. Harbarth ^a

^a Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland 

^b INSERM, IAME, Universite' Paris-Cite', Paris, France 

^c Nephrology Service, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland 

^d Bacteriology Laboratory, Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland 

^e Genomic Research Laboratory, Division of Infectious Diseases, Department of Medicine, University Hospitals and University of Geneva, Geneva, Switzerland 

^⁎Corresponding author.

Le texte complet de cet article est disponible en PDF.